|
![]() |
|||
|
||||
Overview1This collection of review articles highlights the latest development of antithrombotics and provides proven experimental methods for the further development of new and improved anticoagulants. Among the cutting-edge developments reviewed are the novel usage of low molecular weight heparins, such antithrombin agents as the hirudin, and such antiplatelet drugs as the GPIIb/IIIa inhibitors and ADP receptor antagonists. Additional innovations discussed include aspirin and clopidogrel, the expanded use of polytherapeutic approaches, antiproteases (factors IIa, Xa, and VIIa), tissue factor targeting, platelet receptor targeting, and antithrombin III modulation. Full Product DetailsAuthor: Shaker A MousaPublisher: Springer Imprint: Springer Dimensions: Width: 25.40cm , Height: 1.80cm , Length: 17.80cm Weight: 0.572kg ISBN: 9781607618041ISBN 10: 1607618044 Pages: 330 Publication Date: 13 March 2011 Audience: General/trade , General Format: Undefined Publisher's Status: Unknown Availability: Out of stock ![]() Table of ContentsReviews<p>From the reviews: <p><p> This book contains a number of informative topics on the latest advances in the field. Basic science is completed with clinical results. Very complete guidelines for treatment of deep thrombosis and pulmonary embolism ends the book. This recommendable book provides a clinical audience with a complete update on a major field in medicine. (Michel Telerman, Acta Cardiologica, April, 2005) Author InformationTab Content 6Author Website:Countries AvailableAll regions |